骨化三醇改善骨质疏松症对20例慢性阻塞性肺疾病患者的肺功能影响

The treatment of osteoporosis with calcitriol will impact the patient's pulmonary of the chronic obstructive pulmonary disease

目的:评价骨化三醇改善骨质疏松症对慢性阻塞性肺疾病(COPD)患者的肺功能影响。方法:COPD患者20例经骨密度检查为骨质疏松症,连续服用骨化三醇治疗3个月后复查肺功能及血清钙、磷情况。结果:治疗3个月后FEV1及FEV1%、FEV1/FVC%均有提高,血清钙升高,血清磷下降。结论:骨化三醇是治疗COPD合并骨质疏松症的有效药物,并能有效改善COPD患者的肺通气功能。

Objective：To estimate the impact of pulmonary of patients of chronic obstructive pulmonary disease by the treatment of osteoporosis with calcitriol.Methods：Treat osteoporosis of 20 patients of COPD with calcitriol three months and contrast the amelioration of their pulmonary and calcium and phosphonium.Results： The FEV1 、FEV1%、FEV1/FVC% and calcium、phosphonium of the 20 patients ameliorate with osteoporosis rectificated.Conclusions： The treatment of osteoporosis with calcitriol can ameliorate pulmonary ventilation of patients of COPD.